ArticleBlood research2026

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability.

Yuichi Horigome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.